お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、コルチコステロイドAPIの世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別にコルチコステロイドAPI市場を分類しています。
本レポートでは世界のコルチコステロイドAPI市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Pfizer CentreOne、EUROAPI、GlaxoSmithKline、Teva Pharmaceutical Industries、Hovione、Axplora、Steroid SpA、Avik Pharmaceutical、Anuh Pharma、Symbiotec Pharmalab、Sun Pharmaceutical、Cipla、Wellona Pharma、Tianjin Tianyao Pharmaceuticals、Zhejiang Xianju Pharmaceutical、Guangdong Vtr Bio-Tech、Zhejiang Xianju Xianle Pharmaceutical、TIANJIN PACIFIC PHARMACEUTICAL、Shandong Xinhua Pharmaceutica Group、Jiangsu Lianhuan Pharmaceutical、Shanghai New Hualian Pharmaceutical、Shandong Taihua Biotech、Saituo Biological Technology、Zhejiang Xianju Junye Pharmaceutical

レポートはコルチコステロイドAPIの主要生産者を調査し、主要地域や国の消費状況も提供します。コルチコステロイドAPIの今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Prednisone Series
    Dexamethasone Series
    Betamethasone Series
    Hydrocortisone Series
    Others

用途別の市場セグメント：
    Injectable Drugs
    Oral Drugs
    Topical Drugs
    Inhaled Drugs

本レポートの詳細内容
本レポートは、世界のコルチコステロイドAPI市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいてコルチコステロイドAPI市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）のコルチコステロイドAPI生産量、成長率、市場シェアを調査している。

二. 消費面では、コルチコステロイドAPIの売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーのコルチコステロイドAPI売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のコルチコステロイドAPI市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本コルチコステロイドAPIのレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：コルチコステロイドAPIのレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： コルチコステロイドAPIの世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおけるコルチコステロイドAPIの売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章コルチコステロイドAPIメーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：コルチコステロイドAPIの各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：コルチコステロイドAPIの主要メーカーの概要を提供し、製品の説明と仕様、コルチコステロイドAPIの売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：コルチコステロイドAPIの市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

The global Adrenocortical Hormones API market is projected to grow from US$ 2580 million in 2024 to US$ 3582 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period.
Global key players of Adrenocortical Hormones API include Pfizer CentreOne, Sanofi, GlaxoSmithKline, Tianjin Tianyao Pharmaceuticals, Zhejiang Xianju Pharmaceutical, etc. The top five players hold a share over 45%. China is the largest market, which has a share about 35%, followed by Europe and North America with a market share of 25% and 12%, respectively. In terms of product type, Dexamethasone Series is the largest segment, occupied for a share of 35%. And in terms of application, Oral Drugs is the largest segment, which has a share about 49%.
Report Includes
This report presents an overview of global market for Adrenocortical Hormones API, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Adrenocortical Hormones API, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Adrenocortical Hormones API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Adrenocortical Hormones API sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Adrenocortical Hormones API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Adrenocortical Hormones API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer CentreOne, EUROAPI, GlaxoSmithKline, Teva Pharmaceutical Industries, Hovione, Axplora, Steroid SpA, Avik Pharmaceutical, Anuh Pharma, Symbiotec Pharmalab, etc.

Market Segmentation
By Company
    Pfizer CentreOne
    EUROAPI
    GlaxoSmithKline
    Teva Pharmaceutical Industries
    Hovione
    Axplora
    Steroid SpA
    Avik Pharmaceutical
    Anuh Pharma
    Symbiotec Pharmalab
    Sun Pharmaceutical
    Cipla
    Wellona Pharma
    Tianjin Tianyao Pharmaceuticals
    Zhejiang Xianju Pharmaceutical
    Guangdong Vtr Bio-Tech
    Zhejiang Xianju Xianle Pharmaceutical
    TIANJIN PACIFIC PHARMACEUTICAL
    Shandong Xinhua Pharmaceutica Group
    Jiangsu Lianhuan Pharmaceutical
    Shanghai New Hualian Pharmaceutical
    Shandong Taihua Biotech
    Saituo Biological Technology
    Zhejiang Xianju Junye Pharmaceutical

Segment by Type
    Prednisone Series
    Dexamethasone Series
    Betamethasone Series
    Hydrocortisone Series
    Others

Segment by Application
    Injectable Drugs
    Oral Drugs
    Topical Drugs
    Inhaled Drugs

Segment by region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        U.K.
        Italy
        Russia

Middle East, Africa, Latin America
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Adrenocortical Hormones API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Adrenocortical Hormones API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Adrenocortical Hormones API sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
 Table 1. Global Adrenocortical Hormones API Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Table 2. Major Manufacturers of Prednisone Series
 Table 3. Major Manufacturers of Dexamethasone Series
 Table 4. Major Manufacturers of Betamethasone Series
 Table 5. Major Manufacturers of Hydrocortisone Series
 Table 6. Major Manufacturers of Others
 Table 7. Global Adrenocortical Hormones API Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Table 8. Global Adrenocortical Hormones API Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 9. Global Adrenocortical Hormones API Revenue by Region (2019-2024) & (US$ Million)
 Table 10. Global Adrenocortical Hormones API Revenue by Region (2025-2030) & (US$ Million)
 Table 11. Global Adrenocortical Hormones API Revenue Market Share by Region (2019-2024)
 Table 12. Global Adrenocortical Hormones API Revenue Market Share by Region (2025-2030)
 Table 13. Global Adrenocortical Hormones API Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (Tons)
 Table 14. Global Adrenocortical Hormones API Sales by Region (2019-2024) & (Tons)
 Table 15. Global Adrenocortical Hormones API Sales by Region (2025-2030) & (Tons)
 Table 16. Global Adrenocortical Hormones API Sales Market Share by Region (2019-2024)
 Table 17. Global Adrenocortical Hormones API Sales Market Share by Region (2025-2030)
 Table 18. Global Adrenocortical Hormones API Sales by Manufacturers (2019-2024) & (Tons)
 Table 19. Global Adrenocortical Hormones API Sales Share by Manufacturers (2019-2024)
 Table 20. Global Adrenocortical Hormones API Revenue by Manufacturers (2019-2024) & (US$ Million)
 Table 21. Global Adrenocortical Hormones API Revenue Market Share by Manufacturers (2019-2024)
 Table 22. Global Key Players of Adrenocortical Hormones API, Industry Ranking, 2021 VS 2022 VS 2023
 Table 23. Adrenocortical Hormones API Price by Manufacturers (2019-2024) & (US$/kg)
 Table 24. Global Adrenocortical Hormones API Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 25. Global Adrenocortical Hormones API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adrenocortical Hormones API as of 2023)
 Table 26. Global Key Manufacturers of Adrenocortical Hormones API, Manufacturing Base Distribution and Headquarters
 Table 27. Global Key Manufacturers of Adrenocortical Hormones API, Product Offered and Application
 Table 28. Global Key Manufacturers of Adrenocortical Hormones API, Date of Enter into This Industry
 Table 29. Mergers & Acquisitions, Expansion Plans
 Table 30. Global Adrenocortical Hormones API Sales by Type (2019-2024) & (Tons)
 Table 31. Global Adrenocortical Hormones API Sales by Type (2025-2030) & (Tons)
 Table 32. Global Adrenocortical Hormones API Sales Share by Type (2019-2024)
 Table 33. Global Adrenocortical Hormones API Sales Share by Type (2025-2030)
 Table 34. Global Adrenocortical Hormones API Revenue by Type (2019-2024) & (US$ Million)
 Table 35. Global Adrenocortical Hormones API Revenue by Type (2025-2030) & (US$ Million)
 Table 36. Global Adrenocortical Hormones API Revenue Share by Type (2019-2024)
 Table 37. Global Adrenocortical Hormones API Revenue Share by Type (2025-2030)
 Table 38. Adrenocortical Hormones API Price by Type (2019-2024) & (US$/kg)
 Table 39. Global Adrenocortical Hormones API Price Forecast by Type (2025-2030) & (US$/kg)
 Table 40. Global Adrenocortical Hormones API Sales by Application (2019-2024) & (Tons)
 Table 41. Global Adrenocortical Hormones API Sales by Application (2025-2030) & (Tons)
 Table 42. Global Adrenocortical Hormones API Sales Share by Application (2019-2024)
 Table 43. Global Adrenocortical Hormones API Sales Share by Application (2025-2030)
 Table 44. Global Adrenocortical Hormones API Revenue by Application (2019-2024) & (US$ Million)
 Table 45. Global Adrenocortical Hormones API Revenue by Application (2025-2030) & (US$ Million)
 Table 46. Global Adrenocortical Hormones API Revenue Share by Application (2019-2024)
 Table 47. Global Adrenocortical Hormones API Revenue Share by Application (2025-2030)
 Table 48. Adrenocortical Hormones API Price by Application (2019-2024) & (US$/kg)
 Table 49. Global Adrenocortical Hormones API Price Forecast by Application (2025-2030) & (US$/kg)
 Table 50. US & Canada Adrenocortical Hormones API Sales by Type (2019-2024) & (Tons)
 Table 51. US & Canada Adrenocortical Hormones API Sales by Type (2025-2030) & (Tons)
 Table 52. US & Canada Adrenocortical Hormones API Revenue by Type (2019-2024) & (US$ Million)
 Table 53. US & Canada Adrenocortical Hormones API Revenue by Type (2025-2030) & (US$ Million)
 Table 54. US & Canada Adrenocortical Hormones API Sales by Application (2019-2024) & (Tons)
 Table 55. US & Canada Adrenocortical Hormones API Sales by Application (2025-2030) & (Tons)
 Table 56. US & Canada Adrenocortical Hormones API Revenue by Application (2019-2024) & (US$ Million)
 Table 57. US & Canada Adrenocortical Hormones API Revenue by Application (2025-2030) & (US$ Million)
 Table 58. US & Canada Adrenocortical Hormones API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 59. US & Canada Adrenocortical Hormones API Revenue by Country (2019-2024) & (US$ Million)
 Table 60. US & Canada Adrenocortical Hormones API Revenue by Country (2025-2030) & (US$ Million)
 Table 61. US & Canada Adrenocortical Hormones API Sales by Country (2019-2024) & (Tons)
 Table 62. US & Canada Adrenocortical Hormones API Sales by Country (2025-2030) & (Tons)
 Table 63. Europe Adrenocortical Hormones API Sales by Type (2019-2024) & (Tons)
 Table 64. Europe Adrenocortical Hormones API Sales by Type (2025-2030) & (Tons)
 Table 65. Europe Adrenocortical Hormones API Revenue by Type (2019-2024) & (US$ Million)
 Table 66. Europe Adrenocortical Hormones API Revenue by Type (2025-2030) & (US$ Million)
 Table 67. Europe Adrenocortical Hormones API Sales by Application (2019-2024) & (Tons)
 Table 68. Europe Adrenocortical Hormones API Sales by Application (2025-2030) & (Tons)
 Table 69. Europe Adrenocortical Hormones API Revenue by Application (2019-2024) & (US$ Million)
 Table 70. Europe Adrenocortical Hormones API Revenue by Application (2025-2030) & (US$ Million)
 Table 71. Europe Adrenocortical Hormones API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 72. Europe Adrenocortical Hormones API Revenue by Country (2019-2024) & (US$ Million)
 Table 73. Europe Adrenocortical Hormones API Revenue by Country (2025-2030) & (US$ Million)
 Table 74. Europe Adrenocortical Hormones API Sales by Country (2019-2024) & (Tons)
 Table 75. Europe Adrenocortical Hormones API Sales by Country (2025-2030) & (Tons)
 Table 76. China Adrenocortical Hormones API Sales by Type (2019-2024) & (Tons)
 Table 77. China Adrenocortical Hormones API Sales by Type (2025-2030) & (Tons)
 Table 78. China Adrenocortical Hormones API Revenue by Type (2019-2024) & (US$ Million)
 Table 79. China Adrenocortical Hormones API Revenue by Type (2025-2030) & (US$ Million)
 Table 80. China Adrenocortical Hormones API Sales by Application (2019-2024) & (Tons)
 Table 81. China Adrenocortical Hormones API Sales by Application (2025-2030) & (Tons)
 Table 82. China Adrenocortical Hormones API Revenue by Application (2019-2024) & (US$ Million)
 Table 83. China Adrenocortical Hormones API Revenue by Application (2025-2030) & (US$ Million)
 Table 84. Asia Adrenocortical Hormones API Sales by Type (2019-2024) & (Tons)
 Table 85. Asia Adrenocortical Hormones API Sales by Type (2025-2030) & (Tons)
 Table 86. Asia Adrenocortical Hormones API Revenue by Type (2019-2024) & (US$ Million)
 Table 87. Asia Adrenocortical Hormones API Revenue by Type (2025-2030) & (US$ Million)
 Table 88. Asia Adrenocortical Hormones API Sales by Application (2019-2024) & (Tons)
 Table 89. Asia Adrenocortical Hormones API Sales by Application (2025-2030) & (Tons)
 Table 90. Asia Adrenocortical Hormones API Revenue by Application (2019-2024) & (US$ Million)
 Table 91. Asia Adrenocortical Hormones API Revenue by Application (2025-2030) & (US$ Million)
 Table 92. Asia Adrenocortical Hormones API Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 93. Asia Adrenocortical Hormones API Revenue by Region (2019-2024) & (US$ Million)
 Table 94. Asia Adrenocortical Hormones API Revenue by Region (2025-2030) & (US$ Million)
 Table 95. Asia Adrenocortical Hormones API Sales by Region (2019-2024) & (Tons)
 Table 96. Asia Adrenocortical Hormones API Sales by Region (2025-2030) & (Tons)
 Table 97. Middle East, Africa and Latin America Adrenocortical Hormones API Sales by Type (2019-2024) & (Tons)
 Table 98. Middle East, Africa and Latin America Adrenocortical Hormones API Sales by Type (2025-2030) & (Tons)
 Table 99. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue by Type (2019-2024) & (US$ Million)
 Table 100. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue by Type (2025-2030) & (US$ Million)
 Table 101. Middle East, Africa and Latin America Adrenocortical Hormones API Sales by Application (2019-2024) & (Tons)
 Table 102. Middle East, Africa and Latin America Adrenocortical Hormones API Sales by Application (2025-2030) & (Tons)
 Table 103. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue by Application (2019-2024) & (US$ Million)
 Table 104. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue by Application (2025-2030) & (US$ Million)
 Table 105. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 106. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue by Country (2019-2024) & (US$ Million)
 Table 107. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue by Country (2025-2030) & (US$ Million)
 Table 108. Middle East, Africa and Latin America Adrenocortical Hormones API Sales by Country (2019-2024) & (Tons)
 Table 109. Middle East, Africa and Latin America Adrenocortical Hormones API Sales by Country (2025-2030) & (Tons)
 Table 110. Pfizer CentreOne Company Information
 Table 111. Pfizer CentreOne Description and Major Businesses
 Table 112. Pfizer CentreOne Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 113. Pfizer CentreOne Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 114. Pfizer CentreOne Recent Developments
 Table 115. EUROAPI Company Information
 Table 116. EUROAPI Description and Major Businesses
 Table 117. EUROAPI Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 118. EUROAPI Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 119. EUROAPI Recent Developments
 Table 120. GlaxoSmithKline Company Information
 Table 121. GlaxoSmithKline Description and Major Businesses
 Table 122. GlaxoSmithKline Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 123. GlaxoSmithKline Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 124. GlaxoSmithKline Recent Developments
 Table 125. Teva Pharmaceutical Industries Company Information
 Table 126. Teva Pharmaceutical Industries Description and Major Businesses
 Table 127. Teva Pharmaceutical Industries Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 128. Teva Pharmaceutical Industries Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 129. Teva Pharmaceutical Industries Recent Developments
 Table 130. Hovione Company Information
 Table 131. Hovione Description and Major Businesses
 Table 132. Hovione Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 133. Hovione Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 134. Hovione Recent Developments
 Table 135. Axplora Company Information
 Table 136. Axplora Description and Major Businesses
 Table 137. Axplora Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 138. Axplora Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 139. Axplora Recent Developments
 Table 140. Steroid SpA Company Information
 Table 141. Steroid SpA Description and Major Businesses
 Table 142. Steroid SpA Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 143. Steroid SpA Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 144. Steroid SpA Recent Developments
 Table 145. Avik Pharmaceutical Company Information
 Table 146. Avik Pharmaceutical Description and Major Businesses
 Table 147. Avik Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 148. Avik Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 149. Avik Pharmaceutical Recent Developments
 Table 150. Anuh Pharma Company Information
 Table 151. Anuh Pharma Description and Major Businesses
 Table 152. Anuh Pharma Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 153. Anuh Pharma Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 154. Anuh Pharma Recent Developments
 Table 155. Symbiotec Pharmalab Company Information
 Table 156. Symbiotec Pharmalab Description and Major Businesses
 Table 157. Symbiotec Pharmalab Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 158. Symbiotec Pharmalab Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 159. Symbiotec Pharmalab Recent Developments
 Table 160. Sun Pharmaceutical Company Information
 Table 161. Sun Pharmaceutical Description and Major Businesses
 Table 162. Sun Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 163. Sun Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 164. Sun Pharmaceutical Recent Developments
 Table 165. Cipla Company Information
 Table 166. Cipla Description and Major Businesses
 Table 167. Cipla Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 168. Cipla Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 169. Cipla Recent Developments
 Table 170. Wellona Pharma Company Information
 Table 171. Wellona Pharma Description and Major Businesses
 Table 172. Wellona Pharma Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 173. Wellona Pharma Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 174. Wellona Pharma Recent Developments
 Table 175. Tianjin Tianyao Pharmaceuticals Company Information
 Table 176. Tianjin Tianyao Pharmaceuticals Description and Major Businesses
 Table 177. Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 178. Tianjin Tianyao Pharmaceuticals Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 179. Tianjin Tianyao Pharmaceuticals Recent Developments
 Table 180. Zhejiang Xianju Pharmaceutical Company Information
 Table 181. Zhejiang Xianju Pharmaceutical Description and Major Businesses
 Table 182. Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 183. Zhejiang Xianju Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 184. Zhejiang Xianju Pharmaceutical Recent Developments
 Table 185. Guangdong Vtr Bio-Tech Company Information
 Table 186. Guangdong Vtr Bio-Tech Description and Major Businesses
 Table 187. Guangdong Vtr Bio-Tech Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 188. Guangdong Vtr Bio-Tech Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 189. Guangdong Vtr Bio-Tech Recent Developments
 Table 190. Zhejiang Xianju Xianle Pharmaceutical Company Information
 Table 191. Zhejiang Xianju Xianle Pharmaceutical Description and Major Businesses
 Table 192. Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 193. Zhejiang Xianju Xianle Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 194. Zhejiang Xianju Xianle Pharmaceutical Recent Developments
 Table 195. TIANJIN PACIFIC PHARMACEUTICAL Company Information
 Table 196. TIANJIN PACIFIC PHARMACEUTICAL Description and Major Businesses
 Table 197. TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 198. TIANJIN PACIFIC PHARMACEUTICAL Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 199. TIANJIN PACIFIC PHARMACEUTICAL Recent Developments
 Table 200. Shandong Xinhua Pharmaceutica Group Company Information
 Table 201. Shandong Xinhua Pharmaceutica Group Description and Major Businesses
 Table 202. Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 203. Shandong Xinhua Pharmaceutica Group Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 204. Shandong Xinhua Pharmaceutica Group Recent Developments
 Table 205. Jiangsu Lianhuan Pharmaceutical Company Information
 Table 206. Jiangsu Lianhuan Pharmaceutical Description and Major Businesses
 Table 207. Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 208. Jiangsu Lianhuan Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 209. Jiangsu Lianhuan Pharmaceutical Recent Developments
 Table 210. Shanghai New Hualian Pharmaceutical Company Information
 Table 211. Shanghai New Hualian Pharmaceutical Description and Major Businesses
 Table 212. Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 213. Shanghai New Hualian Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 214. Shanghai New Hualian Pharmaceutical Recent Developments
 Table 215. Shandong Taihua Biotech Company Information
 Table 216. Shandong Taihua Biotech Description and Major Businesses
 Table 217. Shandong Taihua Biotech Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 218. Shandong Taihua Biotech Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 219. Shandong Taihua Biotech Recent Developments
 Table 220. Saituo Biological Technology Company Information
 Table 221. Saituo Biological Technology Description and Major Businesses
 Table 222. Saituo Biological Technology Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 223. Saituo Biological Technology Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 224. Saituo Biological Technology Recent Developments
 Table 225. Zhejiang Xianju Junye Pharmaceutical Company Information
 Table 226. Zhejiang Xianju Junye Pharmaceutical Description and Major Businesses
 Table 227. Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2019-2024)
 Table 228. Zhejiang Xianju Junye Pharmaceutical Adrenocortical Hormones API Product Model Numbers, Pictures, Descriptions and Specifications
 Table 229. Zhejiang Xianju Junye Pharmaceutical Recent Developments
 Table 230. Key Raw Materials Lists
 Table 231. Raw Materials Key Suppliers Lists
 Table 232. Adrenocortical Hormones API Distributors List
 Table 233. Adrenocortical Hormones API Customers List
 Table 234. Adrenocortical Hormones API Market Trends
 Table 235. Adrenocortical Hormones API Market Drivers
 Table 236. Adrenocortical Hormones API Market Challenges
 Table 237. Adrenocortical Hormones API Market Restraints
 Table 238. Research Programs/Design for This Report
 Table 239. Key Data Information from Secondary Sources
 Table 240. Key Data Information from Primary Sources


List of Figures
 Figure 1. Adrenocortical Hormones API Product Picture
 Figure 2. Global Adrenocortical Hormones API Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Adrenocortical Hormones API Market Share by Type: 2023 & 2030
 Figure 4. Prednisone Series Product Picture
 Figure 5. Dexamethasone Series Product Picture
 Figure 6. Betamethasone Series Product Picture
 Figure 7. Hydrocortisone Series Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Adrenocortical Hormones API Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 10. Global Adrenocortical Hormones API Market Share by Application: 2023 & 2030
 Figure 11. Injectable Drugs
 Figure 12. Oral Drugs
 Figure 13. Topical Drugs
 Figure 14. Inhaled Drugs
 Figure 15. Adrenocortical Hormones API Report Years Considered
 Figure 16. Global Adrenocortical Hormones API Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 17. Global Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 18. Global Adrenocortical Hormones API Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 19. Global Adrenocortical Hormones API Revenue Market Share by Region in Percentage: 2023 Versus 2030
 Figure 20. Global Adrenocortical Hormones API Revenue Market Share by Region (2019-2030)
 Figure 21. Global Adrenocortical Hormones API Sales (2019-2030) & (Tons)
 Figure 22. Global Adrenocortical Hormones API Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (Tons)
 Figure 23. Global Adrenocortical Hormones API Sales Market Share by Region (2019-2030)
 Figure 24. US & Canada Adrenocortical Hormones API Sales YoY (2019-2030) & (Tons)
 Figure 25. US & Canada Adrenocortical Hormones API Revenue YoY (2019-2030) & (US$ Million)
 Figure 26. Europe Adrenocortical Hormones API Sales YoY (2019-2030) & (Tons)
 Figure 27. Europe Adrenocortical Hormones API Revenue YoY (2019-2030) & (US$ Million)
 Figure 28. China Adrenocortical Hormones API Sales YoY (2019-2030) & (Tons)
 Figure 29. China Adrenocortical Hormones API Revenue YoY (2019-2030) & (US$ Million)
 Figure 30. Asia (excluding China) Adrenocortical Hormones API Sales YoY (2019-2030) & (Tons)
 Figure 31. Asia (excluding China) Adrenocortical Hormones API Revenue YoY (2019-2030) & (US$ Million)
 Figure 32. Middle East, Africa and Latin America Adrenocortical Hormones API Sales YoY (2019-2030) & (Tons)
 Figure 33. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue YoY (2019-2030) & (US$ Million)
 Figure 34. Global Adrenocortical Hormones API Sales Share by Manufacturers (2023)
 Figure 35. The Adrenocortical Hormones API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
 Figure 36. Global Adrenocortical Hormones API Revenue Share by Manufacturers (2023)
 Figure 37. The Top 5 and 10 Largest Manufacturers of Adrenocortical Hormones API in the World: Market Share by Adrenocortical Hormones API Revenue in 2023
 Figure 38. Global Adrenocortical Hormones API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 39. Global Adrenocortical Hormones API Sales Market Share by Type (2019-2030)
 Figure 40. Global Adrenocortical Hormones API Revenue Market Share by Type (2019-2030)
 Figure 41. Global Adrenocortical Hormones API Sales Market Share by Application (2019-2030)
 Figure 42. Global Adrenocortical Hormones API Revenue Market Share by Application (2019-2030)
 Figure 43. US & Canada Adrenocortical Hormones API Sales Market Share by Type (2019-2030)
 Figure 44. US & Canada Adrenocortical Hormones API Revenue Market Share by Type (2019-2030)
 Figure 45. US & Canada Adrenocortical Hormones API Sales Market Share by Application (2019-2030)
 Figure 46. US & Canada Adrenocortical Hormones API Revenue Market Share by Application (2019-2030)
 Figure 47. US & Canada Adrenocortical Hormones API Revenue Share by Country (2019-2030)
 Figure 48. US & Canada Adrenocortical Hormones API Sales Share by Country (2019-2030)
 Figure 49. US Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 50. Canada Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 51. Europe Adrenocortical Hormones API Sales Market Share by Type (2019-2030)
 Figure 52. Europe Adrenocortical Hormones API Revenue Market Share by Type (2019-2030)
 Figure 53. Europe Adrenocortical Hormones API Sales Market Share by Application (2019-2030)
 Figure 54. Europe Adrenocortical Hormones API Revenue Market Share by Application (2019-2030)
 Figure 55. Europe Adrenocortical Hormones API Revenue Share by Country (2019-2030)
 Figure 56. Europe Adrenocortical Hormones API Sales Share by Country (2019-2030)
 Figure 57. Germany Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 58. France Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 59. U.K. Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 60. Italy Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 61. Russia Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 62. China Adrenocortical Hormones API Sales Market Share by Type (2019-2030)
 Figure 63. China Adrenocortical Hormones API Revenue Market Share by Type (2019-2030)
 Figure 64. China Adrenocortical Hormones API Sales Market Share by Application (2019-2030)
 Figure 65. China Adrenocortical Hormones API Revenue Market Share by Application (2019-2030)
 Figure 66. Asia Adrenocortical Hormones API Sales Market Share by Type (2019-2030)
 Figure 67. Asia Adrenocortical Hormones API Revenue Market Share by Type (2019-2030)
 Figure 68. Asia Adrenocortical Hormones API Sales Market Share by Application (2019-2030)
 Figure 69. Asia Adrenocortical Hormones API Revenue Market Share by Application (2019-2030)
 Figure 70. Asia Adrenocortical Hormones API Revenue Share by Region (2019-2030)
 Figure 71. Asia Adrenocortical Hormones API Sales Share by Region (2019-2030)
 Figure 72. Japan Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 73. South Korea Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 74. China Taiwan Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 75. Southeast Asia Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 76. India Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 77. Australia Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 78. Middle East, Africa and Latin America Adrenocortical Hormones API Sales Market Share by Type (2019-2030)
 Figure 79. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue Market Share by Type (2019-2030)
 Figure 80. Middle East, Africa and Latin America Adrenocortical Hormones API Sales Market Share by Application (2019-2030)
 Figure 81. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue Market Share by Application (2019-2030)
 Figure 82. Middle East, Africa and Latin America Adrenocortical Hormones API Revenue Share by Country (2019-2030)
 Figure 83. Middle East, Africa and Latin America Adrenocortical Hormones API Sales Share by Country (2019-2030)
 Figure 84. Brazil Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 85. Mexico Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 86. Turkey Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 87. Israel Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 88. GCC Countries Adrenocortical Hormones API Revenue (2019-2030) & (US$ Million)
 Figure 89. Adrenocortical Hormones API Value Chain
 Figure 90. Adrenocortical Hormones API Production Process
 Figure 91. Channels of Distribution (Direct Vs Distribution)
 Figure 92. Bottom-up and Top-down Approaches for This Report
 Figure 93. Data Triangulation
 Figure 94. Key Executives Interviewed